Susanne Meline

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Los Angeles, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Susanne Meline
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Susanne Meline

Form 4 holding Director

ClearSign Technologies Corp

Security class
Restricted Stock Units
Shares / value
42,870
Estimated value
$48,014
Report date
03 Jan 2023
Price
$1.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Ra Medical Systems, Inc.

Security class
Common Stock
Shares / value
2,575
Estimated value
$1,031
Report date
23 Mar 2023
Price
$0.4002
Ownership
By Spouse
Form 4 holding Director

Ra Medical Systems, Inc.

Security class
Common Stock
Shares / value
800
Estimated value
$320
Report date
09 Jan 2023
Price
$0.4002
Ownership
Indirect
Form 4 holding Director

ClearSign Technologies Corp

Security class
Option to Purchase Common Stock
Shares / value
91,000
Estimated value
Report date
03 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
91,000
Form 4 holding Director

Ra Medical Systems, Inc.

Security class
Series X Convertible Preferred Stock
Shares / value
11
Estimated value
Report date
23 Mar 2023
Price
Ownership
By Spouse
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Susanne Meline

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .